{
    "symbol": "EXPO",
    "quarter": 1,
    "year": 2022,
    "date": "2022-04-30 12:58:05",
    "content": " Exponent\u2019s engineering and other scientific segment represented 81% of our net revenues in the first quarter, increasing 9% as compared to the prior year period, with continued strong demand for Exponent\u2019s services across the utilities, consumer electronics and life sciences sectors. For the first quarter of 2022, total revenues increased 10.3% to $128.5 million and revenues before reimbursements or net revenues, as I will refer to them from here on, increased 7.6% to $117.9 million as compared to the same period in 2021. In the first quarter of 2022, the realized tax benefit for share-based awards was $6 million or $0.11 per diluted share as compared to $8.8 million or $0.16 per diluted share in the first quarter of 2021. Excluding the tax benefit, Exponent\u2019s consolidated tax rate was 28.2% in the quarter as compared to 26.8% for the same period in 2021. EBITDA for the quarter increased 8.6% to $34.5 million, producing a margin of 29.2% of net revenues as compared to 29.0% in the first quarter of 2021. Other operating expenses in the quarter were 5.9% \u2013 I am sorry, were up 5.9% to $8.2 million, driven primarily by increased activity at our offices as employees continue to gradually return."
}